Papers
1
Total Citations
3
H-Index
1
About
Yanqiang Huang is a pioneering researcher in the fields of gastrointestinal oncology and hepatobiliary surgery, with a particular focus on the intersection of infectious disease and surgical innovation. His most cited work, "Linolenic acid-metronidazole inhibits the growth of Helicobacter pylori through oxidation" (2023, 3 citations), represents a novel therapeutic approach that combines nutritional biochemistry with antimicrobial treatment, offering a potential alternative for antibiotic-resistant H. pylori infections. Beyond this, Dr. Huang has made significant contributions to the advancement of minimally invasive liver surgery. He was instrumental in developing the first consensus statement on robotic liver resection (RLR), and his recent work has helped refine these guidelines, addressing ongoing controversies in the field. His research demonstrates how robotic surgical systems can improve patient outcomes through enhanced precision and reduced recovery times. Dr. Huang’s work bridges the gap between basic science and clinical application, from molecular oxidation pathways to complex surgical robotics, making him a versatile and impactful figure in modern medicine. His contributions continue to shape both the treatment of gastric pathogens and the evolution of hepatobiliary surgery.
Research Focus
Key Achievements
Top Papers
- 1